3 months ago
CRVO
AnalystsBoobalan PachaiyappanBoobalan Pachaiyappan's Stock Forecasts
AnalystsBoobalan Pachaiyappan
Sectors:
Industries:
Analyst Ranking
Top 36%
#1756 out of 4922 analysts
Average Return
+3.88%
Win Rate
53%8 out of 15
Risk vs Reward
Poor
Good
Boobalan Pachaiyappan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cervomed IncCRVO | +156.36% | $2.36 | $6.05 | 2025-03-10 - 2025-06-27 | Strong Buy |
Verona Pharma PLCVRNA | +107.57% | $45.20 | $93.82 | 2025-01-09 - 2025-06-27 | Strong Buy |
Gain Therapeutics IncGANX | +23.90% | $1.59 | $1.97 | 2024-12-23 - 2025-06-27 | Strong Buy |
Gain Therapeutics IncGANX | +15.20% | $1.71 | $1.97 | 2024-12-04 - 2025-06-27 | Strong Buy |
Polypid LtdPYPD | +12.97% | $3.16 | $3.57 | 2025-06-04 - 2025-06-27 | Strong Buy |
Boobalan Pachaiyappan Analyst Color
Get additional color on Boobalan Pachaiyappan's coverage of popular stocks
4 months ago
CRVO
Boobalan Pachaiyappan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Verona Pharma PLCVRNA | 2 | Strong Buy | $116.00 | +23.64% | Reiterates | 10 days ago |
Polypid LtdPYPD | 2 | Strong Buy | $9.00 | +152.10% | Maintains | 10 days ago |
Capricor Therapeutics IncCAPR | 1 | Strong Buy | $31.00 | +178.03% | Reiterates | 11 days ago |
Cingulate IncCING | 2 | Strong Buy | $11.00 | +171.60% | Maintains | a month ago |
Cervomed IncCRVO | 3 | Strong Buy | $20.00 | +230.58% | Maintains | 3 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 1 | Strong Buy | $7.00 | +1,971.01% | Initiates Coverage On | 6 months ago |
Gain Therapeutics IncGANX | 2 | Strong Buy | $7.00 | +255.33% | Maintains | 6 months ago |
Entrada Therapeutics IncTRDA | 1 | Strong Buy | $29.00 | +319.68% | Initiates Coverage On | 7 months ago |
Longeveron IncLGVN | 1 | Strong Buy | $10.00 | +657.58% | Initiates Coverage On | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.